Key result
Basal postero-lateral systolic strain accurately predicts myocardial fibrosis in Fabry disease, with AUC ~0.91.
Why the study?
Myocardial fibrosis is common in Fabry cardiomyopathy and associated with disease progression and severe prognosis, but non-invasive methods for its identification need evaluation.
Does two-dimensional speckle tracking echocardiography accurately identify myocardial fibrosis compared to MRI late enhancement in patients with Fabry disease?
Cross-Sectional (n=101)
Does two-dimensional speckle tracking echocardiography accurately identify myocardial fibrosis compared to MRI late enhancement in patients with Fabry disease?
Two-dimensional speckle tracking echocardiography, specifically assessing systolic strain in basal postero-lateral segments, is a highly sensitive and specific non-invasive tool for identifying myocardial fibrosis in Fabry disease.
Answers are grounded in this paper and cite their sources.
May support non-invasive fibrosis screening in Fabry disease; leaves open prospective outcome validation before practice change.
AIMS: This cross-sectional study aimed to analyse myocardial deformation in patients with Fabry disease (FD) in order to evaluate speckle tracking as a method for non-invasive determination of myocardial fibrosis. Myocardial fibrosis is common in Fabry cardiomyopathy and is associated with disease progression and severe prognosis. METHODS AND RESULTS: In 101 consecutive Fabry patients (39.8 ± 12.9 years; 42 males), the quantitative measurement of myocardial fibrosis with magnetic resonance imaging was compared with regional myocardial deformation assessed by speckle-tracking imaging. Patients were analysed in relation to per cent of late-enhancement (LE)-positive areas of left-ventricular (LV) mass. Fifty-two patients (51%) displayed LE with a mean volume of 1.2 ± 1.8% of total LV mass. Predominantly basal lateral and posterior segments were affected. Patients with LE had lower global systolic longitudinal strain than those without (LE -14.8 ± 3.5% and -18.9 ± 2.1%, respectively; P < 0.001). Loss of global deformation, quantified by speckle tracking, was predominantly caused by basal posterior (P = 0.049) and lateral (P = 0.005) segments and global systolic strain correlated with the amount of LE (r = 0.543; P < 0.001). Patients with severe LE (>2%, n = 22) showed the lowest deformation values (-5.9 ± 8.4%) in basal postero-lateral segments when compared with those with mild (<2%; n = 30, -7.1 ± 7.5%) or no LE (n = 49, -16.3 ± 3.3%). These changes were accompanied by thinning of the posterior wall and a decrease in diastolic function, whereas ejection fraction and LV end-diastolic diameter were not different. Receiver operating characteristic analysis revealed that the systolic strain of basal postero-lateral segments was the most powerful predictor to distinguish between patients with and without LE (sensitivity = 90%; specificity = 97%, area under the curve = 0.913; P < 0.001). CONCLUSIONS: Late enhancement is associated with lower longitudinal strain in the fibrotic wall segments. Speckle tracking can be used as a tool for the indirect evaluation of LE in FD.
No takes yet. Share an insight, caveat, or question.
Krämer et al. (2013) conducted a cross-sectional in Fabry disease (n=101). Two-dimensional speckle tracking vs. Magnetic resonance imaging (late enhancement) was evaluated on Global systolic longitudinal strain in patients with versus without late enhancement (p=<0.001). Two-dimensional speckle tracking accurately identified myocardial fibrosis in Fabry disease, with systolic strain of basal postero-lateral segments predicting late enhancement.
Synapse has enriched 10 related papers. Consider them for comparative context: